Memantine and cerebral atrophy Patient Reports February 12, 2012

Memantine Side Effects Report #4875690-X
Memantine side effect was reported by a Health Professional from GERMANY on Dec 20, 2005. Male patient, 82 years of age, was diagnosed with psychotic disorder , essential hypertension, epilepsy  and was treated with Memantine. After drug was administered, patient experienced the following side effects: akinesia, ammonia increased, bedridden, blood pressure increased, body temperature increased, cerebral atrophy, cerebral haematoma, cognitive deterioration. Memantine dosage: 20 MG QD PO. During the same period patient was treated with FUROSEMIDE, VALPROIC ACID, DEPAKINE, APPROVEL, TANAKAN, DOLIPRANE. Patient recovered.

Memantine Side Effects Report #4896758-8
Memantine side effect was reported by a Health Professional from FRANCE on Jan 11, 2006. Male patient, 82 years of age, was diagnosed with psychotic disorder , essential hypertension, epilepsy  and was treated with Memantine. After drug was administered, patient experienced the following side effects: akinesia, ammonia increased, bedridden, body temperature increased, cerebral atrophy, cerebral haematoma, cognitive deterioration, confusional state, difficulty in walking. Memantine dosage: 20 MG QD PO. During the same period patient was treated with FUROSEMIDE, VALPROIC ACID, DEPAKENE, APPROVEL, TANAKAN, ACETAMINOPHEN. Patient recovered.

Memantine Side Effects Report #4666444-8
Memantine side effect was reported by a Health Professional from on May 11, 2005. Female patient, 77 years of age, weighting 146.0 lb, was diagnosed with post herpetic neuralgia and was treated with Memantine. After drug was administered, patient experienced the following side effects: aortic valve incompetence, asthenia, atrioventricular block first degree, balance disorder, cerebral atrophy, confusional state, constipation , difficulty in walking, dizziness . Memantine dosage: unknown. During the same period patient was treated with SYNTHROID, FOSAMAX, ALTACE, HYDROCHLOROTHIAZIDE. Patient was hospitalized. Patient recovered.

Memantine Side Effects Report #5016921-5
Memantine side effect was reported by a Physician from UNITED STATES on May 19, 2006. Female patient, 87 years of age, was diagnosed with dementia alzheimer's type and was treated with Memantine. After drug was administered, patient experienced the following side effects: aneurysm , aortic arteriosclerosis, back pain , blood ph decreased, bronchiectasis, cerebral atrophy, constipation , dementia , hypotension. Memantine dosage: unknown. During the same period patient was treated with NORVASC, OSTEOBIFAX, PRINIVIL, VITAMIN, ASPIRIN, LIDODERM PATCH, KADIAN. Patient was hospitalized. Patient recovered.


Memantine Side Effects Report #4551190-1
Memantine side effect was reported by a Health Professional from on Dec 21, 2004. Female patient, 83 years of age, weighting 154.3 lb, was diagnosed with dementia alzheimer's type and was treated with Memantine. After drug was administered, patient experienced the following side effects: aggression, anorexia, anxiety , atherosclerosis, bladder pain, blood pressure immeasurable, cardiac failure, cerebral atrophy, cold sweat. Memantine dosage: 20 MG QD PO. During the same period patient was treated with BEHEPAN, FOLACIN, KATAIPOS D, OXASCAN, HEMINEURIN, ZOPLIKON. Patient died on 11/14/2004.

Memantine Side Effects Report #4568335-X
Memantine side effect was reported by a Health Professional from on Jan 13, 2005. Female patient, 83 years of age, weighting 154.3 lb, was diagnosed with dementia alzheimer's type and was treated with Memantine. After drug was administered, patient experienced the following side effects: abdominal pain lower, aggression, anxiety , bladder pain, blood pressure immeasurable, bowel sounds abnormal, cerebral atrophy, circulatory collapse, cold sweat. Memantine dosage: 20 MG QD PO. During the same period patient was treated with BEHEPAN, FOLACIN, KATAIPOS D, OXASCAND, HEMINEURIN, ZOPLIKON. Patient died on 11/14/2004.

Memantine Side Effects Report #5675833-4
Memantine side effect was reported by a Pharmacist from UNITED STATES on Mar 03, 2008. Female patient, 78 years of age, was diagnosed with dementia alzheimer's type, prophylaxis urinary tract infection and was treated with Memantine. After drug was administered, patient experienced the following side effects: abasia, aggression, balance disorder, cerebral atrophy, cerebral ischaemia, condition aggravated, constipation , delirium, delusion. Memantine dosage: MG. During the same period patient was treated with CARBIDOPA AND LEVODOPA, TRIMETHOPRIM, DONEPEZIL, FAMOTIDINE, PAROXETINE, LISINOPRIL AND HYDROCHLOROTHIAZIDE. Patient was hospitalized. Patient recovered.

Memantine Side Effects Report #5657878-3
Memantine side effect was reported by a Consumer or non-health professional from JAPAN on Feb 17, 2008. Male patient, 77 years of age, weighting 127.9 lb, was diagnosed with dementia alzheimer's type and was treated with Memantine. After drug was administered, patient experienced the following side effects: activated partial thromboplastin time prolonged, aspartate aminotransferase increased, blood urea increased, cardiac failure, cerebellar infarction, cerebral atrophy, cerebral haemorrhage, haemoglobin decreased, meningitis pneumococcal. Memantine dosage: unknown. During the same period patient was treated with ASPIRIN, AZULENE SULFONATE, CILOSTAZOL, ANTIBIOTICS, NIFEDIPINE, ETHYL ICOSAPENTATE, RILMAZAFONE HYDROCHLORIDE, WARFARIN. Patient was hospitalized and became disabled. Patient recovered.

Memantine Side Effects Report #4669040-1
Memantine side effect was reported by a Consumer or non-health professional from on Feb 03, 2005. Female patient, 74 years of age, weighting 136.7 lb, was diagnosed with dementia alzheimer's type and was treated with Memantine. After drug was administered, patient experienced the following side effects: cerebral atrophy, cerebral infarction, cerebral thrombosis. Memantine dosage: unknown. During the same period patient was treated with PLENDIL, HYDERGINE, GINKO. Patient was hospitalized. Patient recovered.


Memantine Side Effects Report #4693889-2
Memantine side effect was reported by a Consumer or non-health professional from on June 06, 2005. Female patient, 74 years of age, weighting 136.7 lb, was diagnosed with dementia alzheimer's type and was treated with Memantine. After drug was administered, patient experienced the following side effects: cerebral atrophy, cerebral infarction, cerebral thrombosis. Memantine dosage: 20 MG QD PO. During the same period patient was treated with PLENDIL, HYDERGINE, GINKO. Patient was hospitalized. Patient recovered.

Memantine Side Effects Report #4699926-3
Memantine side effect was reported by a Consumer or non-health professional from on June 09, 2005. Female patient, 74 years of age, weighting 136.7 lb, was diagnosed with dementia alzheimer's type and was treated with Memantine. After drug was administered, patient experienced the following side effects: cerebral atrophy, cerebral infarction, cerebral thrombosis. Memantine dosage: 20 MG QD PO. During the same period patient was treated with OKEBDUK, HYDERGINE, GINKO. Patient was hospitalized. Patient recovered.

Memantine Side Effects Report #5328629-7
Memantine side effect was reported by a Consumer or non-health professional from ITALY on Apr 27, 2007. Female patient, 73 years of age, was diagnosed with dementia alzheimer's type and was treated with Memantine. After drug was administered, patient experienced the following side effects: agitation, cerebral atrophy, condition aggravated, gait disturbance, hallucination, visual. Memantine dosage: 5 MG QD PO. During the same period patient was treated with PAROXETINE, GALANTAMINE HYDROBROMIDE, QUETIAPINE FUMARATE, VITAMIN E. Patient was hospitalized. Patient recovered.

Memantine Side Effects Report #5350551-0
Memantine side effect was reported by a Consumer or non-health professional from UNITED STATES on May 21, 2007. Female patient, 63 years of age, was diagnosed with dementia alzheimer's type, colonoscopy  and was treated with Memantine. After drug was administered, patient experienced the following side effects: blood chloride increased, bundle branch block right, carbon dioxide decreased, cerebral atrophy, colorectal cancer , demyelination, disease recurrence, gastrointestinal disorder. Memantine dosage: unknown. During the same period patient was treated with MEPERIDINE, GALANTAMINE HYDROBROMIDE, LEVOTHYROXINE. Patient recovered.

Memantine Side Effects Report #5531274-1
Memantine side effect was reported by a Consumer or non-health professional from GERMANY on Aug 30, 2007. Male patient, 78 years of age, was diagnosed with dementia  and was treated with Memantine. After drug was administered, patient experienced the following side effects: cerebral atrophy, cerebrovascular accident, fall , loss of consciousness. Memantine dosage: unknown. During the same period patient was treated with ASPIRIN, SOTALOL HYDROCHLORIDE, GLICLAZINE, FYBOGEL, SENNA, HYDROXOCOBALAMIN, DONEPEZIL, GALANTAMINE HYDROBROMIDE. Patient was hospitalized. Patient died on 06/30/2007.


Memantine Side Effects Report #4913550-6
Memantine side effect was reported by a Health Professional from SPAIN on Jan 26, 2006. Male patient, 74 years of age, was diagnosed with cognitive deterioration, dementia alzheimer's type and was treated with Memantine. After drug was administered, patient experienced the following side effects: agitation, cerebral atrophy, condition aggravated, dementia , depressed level of consciousness, hallucination, visual, parkinsonism. Memantine dosage: 5 MG QD. During the same period patient was treated with RISPERIDONE, DONEPEZIL, RIVASTIGMINE, ENALAPRIL MALEATE. Patient recovered.

Memantine Side Effects Report #5084559-X
Memantine side effect was reported by a Consumer or non-health professional from BELGIUM on July 06, 2006. Female patient, 86 years of age, was diagnosed with apathy and was treated with Memantine. After drug was administered, patient experienced the following side effects: arrhythmia , cerebral atrophy, leukoaraiosis, psychomotor hyperactivity. Memantine dosage: 5 MG QD PO. During the same period patient was treated with ATORVASTATIN CALCIUM, ASPIRIN, TRAZODONE. Patient was hospitalized. Patient recovered.

Memantine Side Effects Report #5120001-8
Memantine side effect was reported by a Health Professional from BELGIUM on Sept 26, 2006. Female patient, 86 years of age, weighting 180.8 lb, was diagnosed with apathy and was treated with Memantine. After drug was administered, patient experienced the following side effects: arrhythmia , cerebral atrophy, leukoaraiosis, psychomotor hyperactivity. Memantine dosage: 5 MG QD PO. During the same period patient was treated with ATORVASTATIN, ASPIRIN, TRAZODONE. Patient was hospitalized. Patient recovered.

Memantine Side Effects Report #5158519-4
Memantine side effect was reported by a Health Professional from BELGIUM on Nov 14, 2006. Female patient, 86 years of age, weighting 180.8 lb, was diagnosed with apathy and was treated with Memantine. After drug was administered, patient experienced the following side effects: cerebral atrophy, leukoaraiosis, psychomotor hyperactivity. Memantine dosage: 5 MG QD PO. During the same period patient was treated with ATORVASTATIN CALCIUM, ASPIRIN, TRAZODONE. Patient was hospitalized. Patient recovered.

Memantine Side Effects Report #5466864-8
Memantine side effect was reported by a Health Professional from FRANCE on Aug 13, 2007. Male patient, 85 years of age, was treated with Memantine. After drug was administered, patient experienced the following side effects: blood urea increased, cerebral atrophy, dehydration, rhabdomyolysis. Memantine dosage: 10 MG BID PO. During the same period patient was treated with GALANTAMINE HYDROBROMIDE, RISPERDAL. Patient was hospitalized. Patient recovered.


Memantine Side Effects Report #4815952-5
Memantine side effect was reported by a Health Professional from FRANCE on Oct 13, 2005. Female patient, 81 years of age, was treated with Memantine. After drug was administered, patient experienced the following side effects: cerebral atrophy, chorea. Memantine dosage: 20 MG QD PO. During the same period patient was treated with EXELON, DOMPERIDONE, NEURONTIN. Patient was hospitalized. Patient recovered.

Memantine Side Effects Report #5650223-9
Memantine side effect was reported by a Health Professional from FRANCE on Feb 12, 2008. Male patient, 77 years of age, was treated with Memantine. After drug was administered, patient experienced the following side effects: aspiration, brain scan abnormal, cerebral atrophy, coma, convulsion, depressed level of consciousness, disorientation, dyskinesia, electrocardiogram abnormal. Memantine dosage: 20 MG QD;PO. During the same period patient was treated with MIRTAZAPINE, MEPROBAMATE, MODOPAR, THEOSTAT, ZOCOR, PLAVIX. Patient was hospitalized. Patient died on 11/08/2007.

Memantine Side Effects Report #4922710-X
Memantine side effect was reported by a Health Professional from FRANCE on Jan 26, 2006. Male patient, 76 years of age, was treated with Memantine. After drug was administered, patient experienced the following side effects: cerebral atrophy, confusional state, delirium, pyrexia. Memantine dosage: 10 MG QD PO. During the same period patient was treated with COVERSYL, TANAKAN. Patient was hospitalized. Patient recovered.

Memantine Side Effects Report #4930902-9
Memantine side effect was reported by a Health Professional from FRANCE on Feb 20, 2006. Male patient, 76 years of age, was treated with Memantine. After drug was administered, patient experienced the following side effects: cerebral atrophy, confusional state, delirium, pyrexia. Memantine dosage: 10 MG QD PO. During the same period patient was treated with COVERSYL, TANAKAN. Patient was hospitalized. Patient recovered.

Memantine Side Effects Report #5843106-2
Memantine side effect was reported by a Health Professional from GERMANY on July 29, 2008. Male patient, 75 years of age, was treated with Memantine. After drug was administered, patient experienced the following side effects: brain scan abnormal, cerebral atrophy, cerebral ischaemia, electroencephalogram abnormal, grand mal convulsion, somnolence. Memantine dosage: 20 MG 910 MG, 2 IN 1 D), ORAL. During the same period patient was treated with ARICEPT, KARDEGIC, OMIX, FONZYLANE. Patient was hospitalized. Patient recovered.


Memantine Side Effects Report #4596595-8
Memantine side effect was reported by a Physician from on Feb 09, 2005. Female patient, 72 years of age, was treated with Memantine. After drug was administered, patient experienced the following side effects: cerebral atrophy, cerebral ischaemia, confusional state, creatinine renal clearance decreased, depressed level of consciousness, electroencephalogram abnormal, fall , grand mal convulsion, headache . Memantine dosage: 15 MG QD PO. During the same period patient was treated with LATANOPROST, AMLODIPINE BESYLATE, VITAMIN B CAP, VITAMIN E, ASPIRIN. Patient was hospitalized. Patient recovered.

Memantine Side Effects Report #4896456-0
Memantine side effect was reported by a Physician from UNITED STATES on Jan 09, 2006. Female patient, 72 years of age, was treated with Memantine. After drug was administered, patient experienced the following side effects: cerebral atrophy, cerebral ischaemia, creatinine renal clearance decreased, fall , grand mal convulsion, loss of consciousness, postictal headache, screaming. Memantine dosage: 15 MG QD PO. During the same period patient was treated with SERTRALINE, OLANZAPINE, RIVASTIGMINE TARTRATE. Patient was hospitalized. Patient recovered.

Memantine Side Effects Report #5393009-5
Memantine side effect was reported by a Consumer or non-health professional from UNITED STATES on July 06, 2007. Male patient, 62 years of age, was treated with Memantine. After drug was administered, patient experienced the following side effects: arteriosclerosis, cardiac hypertrophy, cerebral atrophy, homicide, poisoning , unresponsive to stimuli. Memantine dosage: 10 MG BID. During the same period patient was treated with DONEPEZIL, CLONAZEPAM, PROPOXYPHENE HYDROCHLORIDE, ACETAMINOPHEN, VENLAFAXINE. Patient died.